QuidelOrtho (QDEL) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

QDEL Stock Forecast


QuidelOrtho (QDEL) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $30.00, with a high of $30.00 and a low of $30.00. This represents a 67.41% increase from the last price of $17.92.

$15 $27 $39 $51 $63 $75 High: $30 Avg: $30 Low: $30 Last Closed Price: $17.92

QDEL Stock Rating


QuidelOrtho stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (46.67%), 6 Hold (40.00%), 2 Sell (13.33%), and 0 Strong Sell (0.00%).

Buy
Total 15 2 6 7 0 Strong Sell Sell Hold Buy Strong Buy

QDEL Price Target Upside V Benchmarks


TypeNameUpside
StockQuidelOrtho67.41%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks25.69%

Price Target Trends


1M3M12M
# Anlaysts-22
Avg Price Target-$32.50$32.50
Last Closing Price$17.92$17.92$17.92
Upside/Downside-81.36%81.36%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26123-17
Feb, 26123-17
Jan, 26123-17
Dec, 25123-17
Nov, 25123-17
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 12, 2026UBS$30.00$23.1929.37%67.41%
Jan 21, 2026UBS$35.00$32.736.94%95.31%
Sep 19, 2024Lu LiUBS$50.00$46.238.15%179.02%
Sep 05, 2024Bill BonelloCraig-Hallum$57.00$42.9332.77%218.08%
Aug 15, 2023Andrew CooperRaymond James$110.00$74.4747.71%513.84%
Dec 12, 2022Citigroup$125.00$92.3035.43%597.54%
Dec 07, 2022RBC Capital$125.00$92.1935.59%597.54%
Oct 14, 2022Elizabeth GarciaUBS$86.00$76.3812.59%379.91%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Feb 12, 2026CitigroupNeutralNeutralhold
Jan 21, 2026UBSNeutralNeutralhold
Oct 07, 2025CitigroupBuyNeutraldowngrade
Dec 11, 2024CitigroupBuyBuyupgrade
Sep 19, 2024UBSBuyBuyhold
Sep 19, 2024UBSNeutralupgrade
Sep 05, 2024Craig-HallumBuyupgrade
May 09, 2024RBC CapitalOutperformOutperformhold
Apr 02, 2024William BlairMarket PerformMarket Performhold
Apr 02, 2024RBC CapitalOutperformOutperformhold

Financial Forecast


EPS Forecast

$-35 $-24 $-13 $-2 $9 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.74$9.66$-0.15$-30.54$-16.69---
Avg Forecast$16.12$14.19$5.01$1.81$2.45$3.34$4.55$5.45
High Forecast$16.34$14.41$5.21$1.91$2.75$16.96$4.64$5.56
Low Forecast$15.90$13.99$4.87$1.74$2.20$-10.29$4.47$5.36
Surprise %3.85%-31.92%-102.99%-1787.29%-781.22%---

Revenue Forecast

$2B $2B $3B $3B $4B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.70B$3.27B$3.00B$2.78B$2.73B---
Avg Forecast$1.57B$3.78B$3.05B$2.77B$2.76B$2.87B$3.00B$3.13B
High Forecast$1.59B$3.82B$3.08B$2.82B$2.80B$2.88B$3.05B$3.18B
Low Forecast$1.56B$3.74B$3.04B$2.76B$2.72B$2.87B$2.96B$3.09B
Surprise %7.89%-13.58%-1.78%0.32%-1.13%---

Net Income Forecast

$-3B $-2B $-700M $200M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$704.20M$548.70M$-10.10M$-2.05B$-1.13B---
Avg Forecast$1.31B$1.44B$-10.10M$121.83M$165.34M$-2.43M$303.94M$364.06M
High Forecast$1.57B$1.72B$-8.08M$127.63M$183.41M$1.13B$309.97M$371.28M
Low Forecast$1.05B$1.15B$-12.12M$116.03M$147.26M$-687.69M$298.77M$357.87M
Surprise %-46.12%-61.77%--1784.36%-784.55%---

QDEL Forecast FAQ


Is QuidelOrtho stock a buy?

QuidelOrtho stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 6 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that QuidelOrtho is a favorable investment for most analysts.

What is QuidelOrtho's price target?

QuidelOrtho's price target, set by 15 Wall Street analysts, averages $30 over the next 12 months. The price target range spans from $30 at the low end to $30 at the high end, suggesting a potential 67.41% change from the previous closing price of $17.92.

How does QuidelOrtho stock forecast compare to its benchmarks?

QuidelOrtho's stock forecast shows a 67.41% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (25.69%).

What is the breakdown of analyst ratings for QuidelOrtho over the past three months?

  • March 2026: 14.29% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.
  • February 2026: 14.29% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.
  • January 2026: 14.29% Strong Buy, 28.57% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.

What is QuidelOrtho’s EPS forecast?

QuidelOrtho's average annual EPS forecast for its fiscal year ending in December 2026 is $3.34, marking a -120.01% decrease from the reported $-16.69 in 2025. Estimates for the following years are $4.55 in 2027, and $5.45 in 2028.

What is QuidelOrtho’s revenue forecast?

QuidelOrtho's average annual revenue forecast for its fiscal year ending in December 2026 is $2.87B, reflecting a 5.28% increase from the reported $2.73B in 2025. The forecast for 2027 is $3B, and $3.13B for 2028.

What is QuidelOrtho’s net income forecast?

QuidelOrtho's net income forecast for the fiscal year ending in December 2026 stands at $-2.434M, representing a -99.78% decrease from the reported $-1.132B in 2025. Projections indicate $303.94M in 2027, and $364.06M in 2028.